Why Benitec More Than Doubled
Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for the treatment of ocular diseases.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 177
Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results
AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.
Why Merck’s Q4 Earnings Aren’t Enough for Investors
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Top 6 Earnings To Watch For On Thursday
Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems the animal spirits powering this rally might not be as positive as they once…
Why Investors Cheered Anthem Earnings
Anthem released a better-than-expected earnings report before the markets opened on Wednesday, pushing shares to a new high.
Obamacare Repeal Cost: 1.2 Million Jobs Nationwide
Repealing Obamacare could cost up to 1.2 million U.S. jobs, and that is not a price that opponents are willing to pay yet.
4 Top Biotech Stocks With Big Upcoming Catalysts
In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.
How Eli Lilly Earnings Won Big on New Drug Sales
Eli Lilly released a mixed fourth-quarter earnings report and offered full-year guidance before the markets opened on Tuesday.
Are Pfizer’s Acquisitions Holding Back Its Bottom Line?
When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.
Is This the Beginning of EyeGate’s Rally?
Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) saw its shares rise handily on Monday following positive top-line results from the company’s first-in-human pilot trial. Specifically, the trial is for the EyeGate Ocular Bandage Gel (OBG) for…
Why the Rigel Pharmaceuticals Update Could Signal Further Growth
Rigel Pharmaceuticals shares saw a solid gain to kick off the week after the company gave an update on one of its clinical programs.
Why This Collaboration Is So Important for Calithera
Shares of Calithera Biosciences saw a solid gain early on Monday after the company reported a global collaboration and licensing agreement with Incyte.
Why the Pulmatrix Pullback Makes Sense
Pulmatrix saw its shares take a sharp downturn on Monday morning after the company announced that it had entered into a definitive agreement with several investors for a direct offering valued up to roughly…
Is This the Formal Implosion of Novan?
Novan saw its shares get absolutely crushed on Friday after the company reported results from its late-stage treatment of acne vulgaris. Analysts took this opportunity to weigh in on the future of this stock.
AbbVie Slides on Mixed Q4 Earnings
AbbVie reported mixed fourth-quarter financial results and offered guidance before the markets opened on Friday.